Identification of Tramadol and its Metabolites in Blood from Drug-Related Deaths and Drug-Impaired Drivers
Authors:
Open Access
- 1 November 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 21 (7) , 529-537
Abstract
Tramadol is a centrally acting, binary analgesic that is neither an opiate-derived nor a nonsteroidal anti-inflammatory drug and that was approved for use in the United States in 1995. It is used to control moderate pain in chronic pain settings such as osteoarthritis and postoperative cases. Used in therapy as a racemic mixture, the (+)-enantiomer weakly binds to the µ-opioid receptor, and both enantiomers inhibit serotonin and norepinephrine reuptake. Tramadol's major active metabolite, O-desmethyltramadol (ODT), shows higher affinity for the µ-opioid receptor and has twice the analgesic potency of the parent drug. The synergism of these effects contributes to tramadol's analgesic properties with the (+)-enantiomer exhibiting 10-fold higher analgesic activity than the (−)-enantiomer. Although tramadol was initially thought to exhibit low abuse potential, Ortho-McNeil, the drug's manufacturer, recently reported a large number of adverse events attributed to tramadol including abuse by opioid-dependent patients, allergic reactions, and seizures. The high number of adverse reactions has prompted the company to update the prescribing information for the drug. An analytical method using gas chromatography-mass spectrometry (GC-MS) without derivatization for the determination of tramadol and its metabolites is reported. An n-butyl chloride extraction is followed by GC-MS analysis using a 5% phenylmethylsilicone column (30 m × 0.32-µm i.d.). Analysis of 12 blood samples from tramadol-related deaths and four nonfatal intoxications involving tramadol revealed concentrations ranging from 0.03 to 22.59 mg/L for tramadol, from 0.02 to 1.84 mg/L for ODT, and from 0.01 to 2.08 mg/L for N-desmethyltramadol. Three deaths were clearly attributable to acute morphine toxicity, one was a doxepin overdose, and six were multiple drug overdoses. The role of tramadol in each death is explored.Keywords
This publication has 13 references indexed in Scilit:
- Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.The Journal of Pharmacology and Experimental Therapeutics, 1995
- Fatal Moclobemide Overdose or Death Caused by Serotonin Syndrome?Journal of Forensic Sciences, 1995
- The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular diseaseThe American Journal of Emergency Medicine, 1994
- Primary and secondary oxidative metabolism of dextromethorphan: In vitro studies with female sprague-dawley and dark agouti rat liver microsomesBiochemical Pharmacology, 1993
- Serotonin syndrome caused by a moclobemide-clomipramine interaction.BMJ, 1993
- Pharmacological receptors on blood platelets.Pharmacological Reviews, 1991
- Abuse potential and pharmacological comparison of tramadol and morphineDrug and Alcohol Dependence, 1991
- Computer-Aided Headspace Gas Chromatography Applied to Blood-Alcohol Analysis: Importance of Online Process ControlJournal of Forensic Sciences, 1989
- Determination of tramadol in human serum by capillary gas chromatography with nitrogen-selective detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Morphine Concentrations and Survival Periods in Acute Heroin FatalitiesNew England Journal of Medicine, 1973